Healthy VolunteersNeuroimaging & Brain MeasuresNeurocognitive DisordersDMTPlacebo

DMT micro-phenomenology

Using micro-phenomenological interviews with 23 participants who received DMT during fMRI, the study shows DMT reliably produces deeply immersive presence experiences that unfold through a characteristic layering—initial multisensory effects followed by spatial, self-related and social reconfigurations. This structural and temporal mapping extends beyond concepts like ego dissolution to advance understanding of DMT's effects and the architecture of conscious experience, and demonstrates the value of systematic first‑person methods for comparing altered states.

Authors

  • Robin Carhart-Harris
  • Christopher Timmermann

Published

Preprints
individual Study

Abstract

DMT reliably induces profound experiences of immersion in other worlds and encounters with seemingly autonomous presences, yet the lived qualities and unfolding of these experiences remain poorly understood. Using micro-phenomenological interviews with twenty-three healthy participants who received DMT during fMRI scanning, this study explores how these experiences arise and develop in awareness. Micro-phenomenological analysis reveals rich dimensions of immersive experience - from multisensory engagement to radical reconfigurations of self and world - and illuminates the varied ways presences can be seen, felt, or otherwise sensed. Rather than focusing on specific content, we follow the micro-phenomenological method to identify the structural features and temporal dynamics that characterise the rich subjective landscape of DMT experience. The findings extend beyond traditional constructs like 'ego dissolution' or 'mystical experience' to reveal how immersion and presence phenomena emerge through specific dimensions, particularly the layering of sensory effects, and subsequent layering of spatial, self-related, and social effects. This detailed phenomenological mapping advances our understanding of both DMT's effects and the architecture of conscious experience, while demonstrating the value of systematic first-person methods for studying profound alterations of consciousness. The findings invite comparative analysis with other transformations of consciousness, such as meditation and lucid dreaming, and especially with presence phenomena observed across different experiential contexts such as lab-induced presence hallucinations, and Parkinson’s disease.

Available with Blossom Pro

Research Summary of 'DMT micro-phenomenology'

Introduction

DMT (N,N-Dimethyltryptamine) is a serotonergic psychedelic that reliably produces vivid immersion in seemingly autonomous other worlds and encounters with perceived presences, as well as profound alterations to self-experience. Sanders and colleagues note that prior work has emphasised the content of these experiences (for example, specific entities or visual motifs) but has not systematically characterised the structural features and temporal dynamics by which such immersive states and presences arise. They argue that a structural focus—differentiating the organisation and unfolding of experience from its particular contents—can yield clearer insight into mechanisms of consciousness and avoid the limitations of broad psychometric constructs (such as ‘‘mystical experience’’ or ‘‘ego dissolution’’) and of coarse retrospective description. This study therefore applies the micro-phenomenological interview and analysis method to examine the structure and micro-temporal development of acute DMT experiences in the laboratory. The central aims were exploratory: to identify the phenomenological dimensions that structure DMT-induced immersion and perceived presences, to map how these dimensions relate over time, and to determine whether consistent temporal sequences or hierarchical dependencies exist during the acute experience. The investigation was embedded in a neurophenomenological protocol to enable later integration with concurrently recorded EEG and fMRI data.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Full Text PDF

Full Paper PDF

Pro members can view the original manuscript directly in the browser.

Study Details

References (17)

Papers cited by this study that are also in Blossom

Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin

Barrett, F. S., Johnson, M. W., Griffiths, R. R. · Journal of Psychopharmacology (2015)

Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial

Falchi, M., Wießner, I., Silva, S. R. B. et al. · European Neuropsychopharmacology (2024)

18 cited
Constructing drug effects: a history of set and setting

Hartogsohn, I. · Drug Science Policy and Law (2017)

389 cited
Phenomenology and Content of the Inhaled N, N-Dimethyltryptamine (N, N-DMT) Experience

Lawrence, D. W., Carhart-Harris, R. L., Griffiths, R. R. et al. · Research Square (2022)

Psychedelics, meditation, and self-consciousness

Milliere, R., Carhart-Harris, R. L., Roseman, L. et al. · Frontiers in Psychology (2018)

The kappa opioid receptor and the sleep of reason: Cortico-subcortical imbalance following salvinorin-A

Ona, G., Sampedro, F., Romero, S. et al. · International Journal of Neuropsychopharmacology (2021)

Neural and subjective effects of inhaled N,N-dimethyltryptamine in natural settings

Pallavicini, C., Cavanna, F., Zamberlan, F. et al. · Journal of Psychopharmacology (2021)

Interrupting the Psychedelic Experience Through Contextual Manipulation to Study Experience Efficacy

Roseman, L., Erritzoe, D., Nutt, D. J. et al. · JAMA Network Open (2024)

Show all 17 references
Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression

Roseman, L., Nutt, D. J., Carhart-Harris, R. L. · Frontiers in Pharmacology (2018)

Moving Past Mysticism in Psychedelic Science

Sanders, J. W. · ACS Pharmacology and Translational Science (2021)

Human brain effects of DMT assessed via EEG-fMRI

Timmermann, C., Roseman, L., Haridas, S. et al. · PNAS (2023)

158 cited
Neural correlates of the DMT experience assessed with multivariate EEG

Timmermann, C., Roseman, L., Schartner, M. et al. · Scientific Reports (2019)

Exploring 5-MeO-DMT as a pharmacological model for deconstructed consciousness

Timmermann, C., Sanders, J. W., Reydellet, D. et al. · Neuroscience of Consciousness (2025)

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.